Partners & Collaborations
JPT Peptide Technologies is an established partner in research projects worldwide. Our network combines partners within universities, research organizations and industry that value JPT’s unmatched peptide synthesis power, R&D specialists and high quality standards according to DIN ISO 9001:2015 certification and GCLP regulations.
JPT offers its services and contract research and development project participation in flexible business arrangements.
Our Business Models are:
- Fee-for-service projects
- FTE based and milestone driven collaboration projects
- Shared risk, partnered development projects
- Participation on publicly granted R&D projects (SME qualification)
Our project partners
- ARBF (Association of Biomolecular Resource Facilities)
- Bayer Pharma AG
- BioNTech AG
- Brighton & Sussex Medical School
- Cancer Immunotherapy Trials Network (CITN)
- Charité Universitätsmedizin Berlin
- CPRG (Centre for Proteomic & Genomic Research)
- Epiontis
- Friedrich-Loeffler-Institut
- Harvard Medical School
- Immudex
- Pfizer Research & Development
- Technical University of Munich (TUM)
- Thermo Fisher Scientific
- SAP
- QIMR Berghofer
- Yale University
- Zellnet
- and various undisclosed partners
Our Track Record
JPT has run several successful projects in different scientific fields:
Immunotherapy & Vaccines
- Peptide selection and synthesis for individualized neo-epitope based vaccination strategies
- Peptide pool design and synthesis for adoptive cell transfer therapy
- Design of comprehensive peptide libraries for companion diagnostics and treatment
- Identification of serological predictive, prognostic, and surrogate biomarkers
- Proteome-spanning vaccine target discovery
- Deep T-cell epitope discovery
Proteomics
- Development of next generation standards for targeted proteomics
- Characterization of specificity profiles for proteins and protein families
- Design and synthesis of peptide libraries for proteome wide detection and quantification of proteins
- Development of molecular probes for the multiplexed detection and quantification of proteins from biological samples
- Discovery of proteotypic peptide markers for functional proteomics
- Identification of epigenetic states of proteins and characterization of enzymatic alterations
Drug Discovery
- Design and production of screening libraries, peptides and peptidomimetics
- Identification and optimization of agonistic and antagonistic ligands
- Identification and optimization of affinity ligands
- Identification and optimization of stabilizing peptides as excipients
- Development of surrogate bioassays for antigen-free detection of therapeutic protein
- Substrate identification and optimization for several orphan enzymes for screening assays
Loading...
